Catecholaminergic polymorphic ventricular tachycardia risk factors: Difference between revisions
No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 2: | Line 2: | ||
{{Catecholaminergic polymorphic ventricular tachycardia}} | {{Catecholaminergic polymorphic ventricular tachycardia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MRV}} | ||
==Overview== | ==Overview== | ||
Possible risk factors in the development of catecholaminergic polymorphic ventricular tachycardia (CPVT) include young age, exercise, stress, family history of [[syncope]], or [[sudden death]], and family history of [[CPVT]]. | |||
==Risk Factors== | ==Risk Factors== |
Latest revision as of 15:29, 23 July 2020
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Catecholaminergic polymorphic ventricular tachycardia risk factors On the Web |
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia risk factors |
FDA on Catecholaminergic polymorphic ventricular tachycardia risk factors |
CDC on Catecholaminergic polymorphic ventricular tachycardia risk factors |
Catecholaminergic polymorphic ventricular tachycardia risk factors in the news |
Blogs on Catecholaminergic polymorphic ventricular tachycardia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Possible risk factors in the development of catecholaminergic polymorphic ventricular tachycardia (CPVT) include young age, exercise, stress, family history of syncope, or sudden death, and family history of CPVT.
Risk Factors
The possible risk factors in the development of catecholaminergic polymorphic ventricular tachycardia (CPVT) include:[1][2]
- Physical activity such as exercise,
- Stress,
- Young age,
- Family history of syncope or sudden death, and
- Family history of CPVT.
References
- ↑ Hayashi, Meiso; Denjoy, Isabelle; Extramiana, Fabrice; Maltret, Alice; Buisson, Nathalie Roux; Lupoglazoff, Jean-Marc; Klug, Didier; Hayashi, Miyuki; Takatsuki, Seiji; Villain, Elisabeth; Kamblock, Joël; Messali, Anne; Guicheney, Pascale; Lunardi, Joël; Leenhardt, Antoine (2009). "Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation. 119 (18): 2426–2434. doi:10.1161/CIRCULATIONAHA.108.829267. ISSN 0009-7322.
- ↑ Leenhardt, Antoine; Denjoy, Isabelle; Guicheney, Pascale (2012). "Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation: Arrhythmia and Electrophysiology. 5 (5): 1044–1052. doi:10.1161/CIRCEP.111.962027. ISSN 1941-3149.